Efficacy of three filgrastim‐intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico
Author:
Affiliation:
1. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Hematology DepartmentUniversidad Autónoma de Nuevo León Monterrey Nuevo León Mexico
Publisher
Wiley
Subject
Hematology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21707
Reference32 articles.
1. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey
2. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony‐stimulating factor);Schmitz N;Blood,1995
3. Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association
4. Ethical issues and concerns about the use of biosimilar granulocyte colony‐stimulating factors for the mobilisation of stem cells in normal donors;Liumbruno GM;Blood Transfus,2012
5. Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparing the effectiveness of biosimilar filgrastim (Nivestim®) versus original filgrastim (Neupogen®) for stem cell mobilization in adult and pediatric healthy donors;Journal of Oncology Pharmacy Practice;2023-06-26
2. Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation;Hematology, Transfusion and Cell Therapy;2022-09
3. Conducting hematopoietic stem cell transplantation in low and middle income countries;Hematology;2022-07-27
4. The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors;International Journal of Hematology;2022-04-09
5. Lessons Learned Treating Patients with Multiple Myeloma in Resource-Constrained Settings;Current Hematologic Malignancy Reports;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3